{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:05:12Z","timestamp":1790928312804,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Despite the high incidence of cervical cancer reported from India, large scale population based studies on the HPV prevalence and genotype distribution are very few from this region. In view of the clinical trials for HPV vaccine taking place in India, it is of utmost importance to understand the prevalence of HPV genotypes in various geographical regions of India. We investigated the genotype distribution of high-risk HPV types in squamous cell carcinomas and the prevalence of high-risk HPV in cervicovaginal samples in the southern state of Andhra Pradesh (AP), India.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>HPV genotyping was done in cervical cancer specimens (n = 41) obtained from women attending a regional cancer hospital in Hyderabad. HPV-DNA testing was also done in cervicovaginal samples (n = 185) collected from women enrolled in the cervical cancer screening pilot study conducted in the rural community, of Medchal Mandal, twenty kilometers away from Hyderabad.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>High-risk HPV types were found in 87.8% (n = 36\/41) of the squamous cell carcinomas using a PCR-based line blot assay. Among the HPV positive cancers, the overall type distribution of the major high-risk HPV types was as follows: HPV 16 (66.7%), HPV 18 (19.4%), HPV 33 (5.6%), HPV 35 (5.6%), HPV 45 (5.6%), HPV 52 (2.8%), HPV 58(2.8%), HPV 59(2.8%) and HPV 73 (2.8%). Women participating in the community screening programme provided both a self-collected vaginal swab and a clinician-collected cervical swab for HPV DNA testing. Primary screening for high risk HPV was performed using the Digene Hybrid Capture 2 (hc2) assay. All hc2 positive samples by any one method of collection were further analyzed using the Roche PCR-based line blot for genotype determination. The prevalence of high risk HPV infection in this community-based screening population was 10.3% (19\/185) using the clinician-collected and 7.0% (13\/185) using the self-collected samples. The overall agreement between self-collected and clinician-collected samples was 92%; however among HPV-positive specimens, the HPV agreement was only moderate (39.1%). The most frequently detected HPV types in the Medchal community are HPV 52 and 16.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our results suggest that the HPV type distribution in both cervical cancer tissues and in a general screening population from Andhra Pradesh is similar to that reported in India and other parts of the world. We also conclude that an effective vaccine targeting HPV 16 will reduce the cervical cancer burden in AP.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-5-116","type":"journal-article","created":{"date-parts":[[2005,12,22]],"date-time":"2005-12-22T07:14:35Z","timestamp":1135235675000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India"],"prefix":"10.1186","volume":"5","author":[{"given":"A Pavani","family":"Sowjanya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenkashi","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha Rani","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Padma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manik","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerti V","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BN","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha Rama","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patti E","family":"Gravitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayatri","family":"Ramakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,12,22]]},"reference":[{"key":"264_CR1","first-page":"49","volume":"98","author":"V Shanta","year":"2000","unstructured":"Shanta V, Krishnamurthi S, Gajalakshmi CK, Swaminathan R, Ravichandran K: Epidemiology of cancer of the cervix: global and national perspective. J Indian Med Assoc. 2000, 98: 49-52.","journal-title":"J Indian Med Assoc"},{"key":"264_CR2","first-page":"226","volume":"5","author":"SK Pal","year":"2004","unstructured":"Pal SK, Mittal B: Improving cancer care in India: prospects and challenges. Asian Pac J Cancer Prev. 2004, 5: 226-8.","journal-title":"Asian Pac J Cancer Prev"},{"key":"264_CR3","first-page":"106s","volume":"19","author":"Rakesh Chopra","year":"2001","unstructured":"Rakesh Chopra : The Indian Scene. Journal of Clinical Oncology. 2001, 19: 106s-111s.","journal-title":"Journal of Clinical Oncology"},{"key":"264_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1023\/A:1008900425151","volume":"11","author":"R Rajkumar","year":"2000","unstructured":"Rajkumar R, Sankaranarayanan R, Esmi A, Jayaraman R, Cherian J, Parkin DM: Leads to cancer control based on cancer patterns in a rural population in South India. Cancer Causes Control. 2000, 11: 433-9. 10.1023\/A:1008900425151.","journal-title":"Cancer Causes Control"},{"key":"264_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/01443610220141434","volume":"22","author":"S Chhabra","year":"2002","unstructured":"Chhabra S, Sonak M, Prem V, Sharma S: Gynaecological malignancies in a rural institute in India. J Obstet Gynaecol. 2002, 22: 426-9. 10.1080\/01443610220141434.","journal-title":"J Obstet Gynaecol"},{"key":"264_CR6","first-page":"57","volume":"37","author":"S Gavarasana","year":"2000","unstructured":"Gavarasana S, Kalasapudi RS, Rao TD, Thirumala S: Prevention of carcinoma of cervix with human papillomavirus vaccine. Indian J Cancer. 2000, 37: 57-66.","journal-title":"Indian J Cancer"},{"key":"264_CR7","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1056\/NEJMoa020586","volume":"347","author":"LA Koutsky","year":"2002","unstructured":"Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU: Proof of Principle Study InvestigatorsA controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2002, 347: 1645-51. 10.1056\/NEJMoa020586.","journal-title":"N Engl J Med"},{"key":"264_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/01.ogx.0000154423.27940.68","volume":"60","author":"DM Harper","year":"2005","unstructured":"Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, Decarvalho NS, Roteli-Martins CM, Teixeira J, Blotter MM, Kom AP, Quint W, Dubin G: for the GlaxoSmithKline HPV Study Group. Efficacy of a Bivalent L1 Virus-Like Particle Vaccine in Prevention of Infection With Human Papillomavirus Types 16 and 18 in Young Women: A Randomized Trial. Obstet Gynecol Surv. 2005, 60: 171-173. 10.1097\/01.ogx.0000154423.27940.68.","journal-title":"Obstet Gynecol Surv"},{"key":"264_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ijc.20244","volume":"111","author":"N Munoz","year":"2004","unstructured":"Munoz N, Bosch FX, Castellsague X, Diaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ: Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004, 111: 278-85. 10.1002\/ijc.20244.","journal-title":"Int J Cancer"},{"key":"264_CR10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.vaccine.2004.07.046","volume":"23","author":"SR Pagliusi","year":"2004","unstructured":"Pagliusi SR, Teresa Aguado M: Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine. 2004, 23: 569-578. 10.1016\/j.vaccine.2004.07.046.","journal-title":"Vaccine"},{"key":"264_CR11","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S1470-2045(02)00916-6","volume":"3","author":"DC Sharma","year":"2002","unstructured":"Sharma DC: HPV vaccine trial may take place in India. Lancet Oncol. 2002, 3: 649-10.1016\/S1470-2045(02)00916-6.","journal-title":"Lancet Oncol"},{"key":"264_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/ijc.11350","volume":"107","author":"S Franceschi","year":"2003","unstructured":"Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJ, Munoz N, Meijer CJ, Herrero R: Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J Cancer. 2003, 107: 127-33. 10.1002\/ijc.11350.","journal-title":"Int J Cancer"},{"key":"264_CR13","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/S0140-6736(89)91870-9","volume":"2","author":"BC Das","year":"1989","unstructured":"Das BC, Sehgal A, Murthy NS, Gopalkrishna V, Sharma JK, Das DK, Singh V, Luthra UK: Human papillomavirus and cervical cancer in Indian women. Lancet. 1989, 2: 1271-10.1016\/S0140-6736(89)91870-9.","journal-title":"Lancet"},{"key":"264_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/sj.bjc.6602580","volume":"92","author":"S Franceschi","year":"2005","unstructured":"Franceschi S, Rajkumar R, Snijders PJ, Arslan A, Mahe C, Plummer M, Sankaranarayanan R, Cherian J, Meijer CJ, Weiderpass E: Papillomavirus infection in rural women in southern India. Br J Cancer. 2005, 92: 601-6. 10.1038\/sj.bjc.6602580.","journal-title":"Br J Cancer"},{"key":"264_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ijc.21050","volume":"116","author":"R Sankaranarayanan","year":"2005","unstructured":"Sankaranarayanan R, Nene BM, Dinshaw KA, Mahe C, Jayant K, Shastri SS, Malvi SG, Chinoy R, Kelkar R, Budukh AM, Keskar V, Rajeshwarker R, Muwonge R, Kane S, Parkin DM, Chauhan MK, Desai S, Fontaniere B, Frappart L, Kothari A, Lucas E, Panse N, Osmanabad District Cervical Screening Study Group: A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer. 2005, 116: 617-23. 10.1002\/ijc.21050.","journal-title":"Int J Cancer"},{"key":"264_CR16","volume-title":"Preparation and ananlysis of DNA. Short protocols in molecular biology","year":"1995","unstructured":"Preparation and ananlysis of DNA. Short protocols in molecular biology. Edited by: Ausubel et al. 1995, New York: Wiley, 3","edition":"3"},{"key":"264_CR17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.38.1.357-361.2000","volume":"38","author":"PE Gravitt","year":"2000","unstructured":"Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ: Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000, 38: 357-61.","journal-title":"J Clin Microbiol"},{"key":"264_CR18","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1128\/JCM.36.10.3020-3027.1998","volume":"36","author":"PE Gravitt","year":"1998","unstructured":"Gravitt PE, Peyton CL, Apple RJ, Wheeler CM: Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol. 1998, 36: 3020-7.","journal-title":"J Clin Microbiol"},{"key":"264_CR19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348: 518-27. 10.1056\/NEJMoa021641.","journal-title":"N Engl J Med"},{"key":"264_CR20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","volume":"87","author":"FX Bosch","year":"1995","unstructured":"Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995, 87: 796-802.","journal-title":"J Natl Cancer Inst"},{"key":"264_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-9. 10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.","journal-title":"J Pathol"},{"key":"264_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1386-6532(00)00125-6","volume":"19","author":"N Munoz","year":"2000","unstructured":"Munoz N: Human papillomavirus and cancer the epidemiological evidence. J Clin Virol. 2000, 19: 1-5. 10.1016\/S1386-6532(00)00125-6.","journal-title":"J Clin Virol"},{"key":"264_CR23","unstructured":"[http:\/\/www.canceratlasindia.org]"},{"key":"264_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","volume":"88","author":"GM Clifford","year":"2003","unstructured":"Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003, 88: 63-73. 10.1038\/sj.bjc.6600688.","journal-title":"Br J Cancer"},{"key":"264_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476","volume":"31","author":"M Schiffman","year":"2003","unstructured":"Schiffman M, Kjaer SK: Natural history of anogenital human Papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr. 2003, 31: 14-9.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"264_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/ijc.20396","volume":"112","author":"R Sankaranarayanan","year":"2004","unstructured":"Sankaranarayanan R, Chatterji R, Shastri SS, Wesley RS, Basu P, Mahe C, Muwonge R, Seigneurin D, Somanathan T, Roy C, Kelkar R, Chinoy R, Dinshaw K, Mandal R, Amin G, Goswami S, Pal S, Patil S, Dhakad N, Frappart L, Fontaniere B: Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Int J Cancer. 2004, 112: 341-7. 10.1002\/ijc.20396.","journal-title":"Int J Cancer"},{"key":"264_CR27","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/ijc.21220","volume":"117","author":"R Legood","year":"2005","unstructured":"Legood R, Gray AM, Mahe C, Wolstenholme J, Jayant K, Nene BM, Shastri SS, Malvi SG, Muwonge R, Budukh AM, Sankaranarayanan R: Screening for cervical cancer in India How much will it cost? A trial based analysis of the cost per case detected. Int J Cancer. 2005, 117: 981-7. 10.1002\/ijc.21220.","journal-title":"Int J Cancer"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-5-116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-5-116\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-5-116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-5-116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T21:18:04Z","timestamp":1630444684000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-5-116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["264"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-5-116","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"17 June 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"116"}}